StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
MUKKA.BO$22.43+0.90%
Fair $22.43+0.0%

MUKKA.BO

Mukka Proteins Limited

Consumer Defensive / Packaged FoodsBSE

$22.43

+0.20 (+0.90%)

Fairly Valued+0.0%Fair Value $22.43Fund rank 23/100 · Data gapFallback financials|
SA 34/D
F-Score: 2/9

FCF base 3Y

n/d

n/d CAGR · yield n/d

FCF base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 34% · confianza 19%

FCF escenarios

weak_data · normalized FCF $-1.7B · quality 49.0/100

Data gap 23/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 28/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

34/100

D

Piotroski

2/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

16/100

SEC 0%

Latest source: unknownPeriods: 4Warnings: 0unknown: 4
No SEC-backed annual rows; valuation uses fallback financial data. Insufficient audited annual history (<3 SEC-backed years); composite fair value and forward targets are disabled until manually verified.
Thesis & Journal · MUKKA.BOLocal privado en este navegador · Mukka Proteins Limited
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$6.7B

P/E

12.9x

↓

EV/EBITDA

9.9x

↑

ROE

10.4%

↑

Gross Margin

16.7%

↓

Debt/Equity

1.56

↑
52-Week Range$22
$18$33

TradingView lightweight chart

MUKKA.BO price, volumen y niveles de valoración

Último $22.43Periodo -46.9%
Fair value: $22.43

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2023–2026 · 3 años de histórico normalizado

Revenue CAGR

+6.7%

FCF CAGR

—

FCF margin

-16.5%

FCF / Net income

-4.45x

Latest source

Provider fallback

Margin decomposition

Último año: revenue $14.04B · net income $520.6M · FCF $-2.32B

2023-FY → 2026-FY

Gross margin

16.7%+1.9% pts

Operating margin

7.0%+0.0% pts

Net margin

3.7%-0.1% pts

FCF margin

-16.5%-10.9% pts
MetricTTM
2026
2025
2024
2023
Income Statement
Revenue$14.04B$14.04B$9.80B$13.42B$11.56B
Net Income$520.6M$520.6M$464.6M$700.5M$440.8M
EBITDA$1.45B$1.45B$1.11B$1.19B$894.6M
EPS1.741.741.553.101.47
Gross Margin16.7%16.7%21.0%12.9%14.8%
Operating Margin7.0%7.0%8.3%7.0%6.9%
Net Margin3.7%3.7%4.7%5.2%3.8%
Balance Sheet
Debt/Equity1.561.561.030.921.77
Current Ratio1.231.23———
Cash Flow
Free Cash Flow$-2.32B$-2.32B$-1.32B$-1.66B$-645.4M
Returns
ROE10.4%10.4%10.5%17.7%29.8%
Valuation
P/E12.8912.8921.1812.23—
EV/EBITDA9.899.8912.919.48—
P/B1.341.342.232.16—
Growth & Yield
Revenue Growth43.2%43.2%-27.0%16.1%—
EPS Growth12.3%12.3%-50.0%111.0%—

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Leverage & Liquidity

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%

3Y implied EPS CAGR

4.6%

fácil

EPS terminal req.

$1.99

Spread vs growth

7.7%

5Y implied EPS CAGR

6.7%

razonable

EPS terminal req.

$2.41

Spread vs growth

5.5%

10Y implied EPS CAGR

8.3%

razonable

EPS terminal req.

$3.88

Spread vs growth

3.9%

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · 1Y approxreconcilia total -27.2%

Total return

-27.2%

Start / end P/E

19.9x → 12.9x

EPS bridge

1.55 → 1.74

Residual

-4.3%

EPS growth+12.3%
Multiple rerating-35.1%
Dividend+0.0%
Residual / FX / buybacks / cross-term-4.3%

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.